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The clinical utility of structural neuroimaging in first episode psychosis: a systematic 
review  
 
Abstract 
Background: Australian and US guidelines recommend routine brain imaging, either 
computed tomography (CT) or magnetic resonance imaging (MRI), to exclude structural 
lesions in presentations for first-episode psychosis. The aim of this review was to examine the 
evidence for the appropriateness and clinical utility of this recommendation by assessing the 
frequency of abnormal radiological findings in CT and MRI scans among patients with first-
episode psychosis.  
Methods: PubMed and Embase database were searched from inception to April 2018 using 
appropriate MeSH or Emtree terms. Studies were included in the review if they reported data 
on CT or MRI scan findings of individuals with first-episode psychosis. No restriction on the 
geographical location of the study or the age of participants was applied. We calculated the 
percentage of abnormal radiological findings in each study, separately by the two diagnostic 
methods. 
Results:  There were 16 suitable studies published between 1988 and 2017, reporting data on 
an overall 2312 patients with first-episode psychosis.  Most were observational studies with 
retrospective design and majority examined patients with CT. While structural abnormalities 
were a relatively common finding, these rarely required clinical intervention (range across 
studies: 0-60.7%; median: 3.5%) and were very rarely the cause of the psychotic symptoms 
(range: 0-3.3%; median: 0%). Only two of the 16 studies concluded that brain imaging should 
be routinely ordered in first-episode psychosis.  
Conclusion: There is insufficient evidence to suggest that brain imaging should be routinely 
ordered for patients presenting with first-episode psychosis without associated neurological or 
cognitive impairment. The appropriate screening procedure for structural brain lesions is 
conventional history-taking, mental status, and neurological examination. If intracranial 
pathology is suspected clinically, an MRI or CT scan should be performed depending on the 
clinical signs, the acuity and the suspected pathology. National guidelines should reflect 
evidence-based data.  
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Introduction  
 Since Weinberger first proposed the use of computed tomography in first-episode 
psychosis in 1984, neuroimaging has been part of the medical work-up of these cases to exclude 
contributory neurological conditions (Weinberger, 1984). Recommendations for brain imaging 
have been incorporated into practice guidelines although considerable disparity remains among 
national guidelines about whether scanning should be routinely undertaken (Table 1).   
The aim of this study is to systematically review the evidence for the clinical utility of 
computed tomography (CT) or magnetic resonance imaging (MRI) in first-episode psychosis. 
In particular, we assessed the frequency of abnormal radiological findings in CT and MRI scans 
among patients who were admitted to hospital with first-episode psychosis. This review 
updates previous reviews by Albon et al. (2008) Goulet et al (2009) and The National Institute 
for Health and Care Excellence (NICE, 2011) with new data. All of these reviews have 
concluded that routine neuroimaging is not indicated in first-episode psychosis.  
 
Method  
The methods are based on the Preferred Reporting Items for Systematic Review and 
Meta-Analyses (PRISMA) (Moher et al., 2009). We searched PubMed and Embase up to April 
2018 using the following text, MeSH or Emtree terms as appropriate: (early OR first OR first-
episode OR "first episode") AND (psychosis OR psychotic OR schizophreniform) AND 
(neuroimaging OR "brain imaging" OR CT OR MRI OR "computed tomography" OR 
"magnetic resonance imaging"). The initial search was performed by MF. The selected 
abstracts (109 papers) were reviewed by MF, DS and MB to determine if they met inclusion 
criteria. We (MF, DS, MB) searched for further publications by scrutinising the reference lists 
of initial studies identified and other relevant review papers. MF contacted selected authors 
and experts to obtain further data where necessary. Radiological findings were classified by 
two authors (DV, SS). Conflicts between the three reviewers were resolved by discussion. 
Our inclusion criteria were as follows: retrospective or prospective studies with primary 
data collection that included data on the radiological findings in individuals with first-episode 
psychosis. We applied no restriction on the geographical location of the study or the age of 
participants. We excluded studies that did not specifically state participants had first-episode 
psychosis and excluded morphological brain studies that provided volumetric or other data but 
did not provide radiological diagnosis. Only English-language studies were included. 
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In the data extraction phase, information on study design, number, age and sex of 
participants, as well as on the field-strength of MRI scan methods (if available) was collected 
from all included studies. We utilised the same methodology as used by Goulet et al (2009) 
and classified brain scans as:  
1. Normal;  
2. Abnormal, with radiological findings having no clinical impact: benign or nonspecific 
findings with no implication on diagnosis, management, or treatment;  
3. Abnormal, with radiological findings having an implication on management or 
treatment, but an unlikely causal link to psychotic symptoms;  
4. Abnormal, with radiological findings having an implication on management or 
treatment, and a possible causal link to psychotic symptoms.  
The number of patients who belonged to any of the above categories, together with their 
radiological diagnosis in case of abnormal findings, was extracted from each study. From this 
information, we calculated the percentage of patients with these outcomes from all scanned 
individuals. Data are presented separately in each study by CT and MRI scans. The data 
extraction procedure was led by the first author (MF), but DS and MB also checked the 
accuracy of reported values. 
We (MF, DS, MB) independently assessed methodological quality using a modified version of 
quality assessment tool used by Rao et al (2005) which rates studies examining the clinical 
utility of a test based on details of study sample and patient selection, data collection, and 
verification and details of the test (Table 2).  
 
Results  
 There were 2314 citations of interest in the initial electronic searches, of which 109 
abstracts were screened. Of these, 22 full-text papers were potentially relevant and assessed for 
eligibility. Nine papers were excluded for reasons listed in Figure 1. Three additional papers 
were found from the reference lists of other papers from the database search. This left 16 
papers, six which were published since the most recent review (NICE, 2011) (Figure 1).  For 
each paper, the percentage of participants with the specific outcome was provided according 
to the classification system outlined above.  
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Thirteen of the 16 studies were retrospective audits of medical records, two were 
prospective case series and one was a case-control study (Table 3). Sample sizes ranged from 
30 to 349, and overall, they examined 2312 patients. Two studies considered the diagnostic 
characteristics of tests (sensitivity, specificity) and the costs of potentially unnecessary scans 
but none provided details or an economic analysis. None of the studies gave follow-up data 
and none were randomised controlled trials or before-after studies. Six papers came from the 
United States, three from Australia, two each from the UK and Canada, and one from 
Switzerland, the Netherlands and Portugal.  
The included studies were of variable quality. From the maximum possible quality 
score of six points, seven studies scored four or five, and were considered as adequate or high 
quality. On the other hand, six of the reviewed studies had an overall score of one or two, 
suggesting low quality (Table 4).  
Computed tomography  
 In  one retrospective analysis (Bain, 1998) there were 4 incidental radiological 
abnormalities of 127 individuals scanned, none of which were causally related to psychosis 
while in another of 52 patients with first-episode psychosis (McKay et al., 2006), none had 
abnormalities potentially related to psychosis. The same finding was made in a retrospective 
analyses of 75 patients (Compton et al., 2009) and of 98 patients (Adams et al., 1996). Further, 
Strahl et al (2010) reviewed 237 consecutive patients who had CT scans for first-episode 
psychosis with no focal neurological signs. None of those scanned had abnormalities related to 
psychosis. 
In a retrospective analysis (Gewirtz et al., 1994) one of the 168 individuals scanned 
(0.6%) had incidental findings that may have been causally related to psychosis. Individuals 
were examined but it is unclear whether neurological findings on clinical examination were 
present in the individuals with psychosis. In another study, this time a prospective diagnostic 
case series (Battaglia and Spector, 1988),  three of 45 individuals had incidental abnormalities  
although none of these abnormalities considered implicated in psychosis. This study excluded 
individuals with drug-induced psychosis, thus the ‘hit rate’ for identifying lesions responsible 
for psychosis was likely higher than studies that did not exclude this group.  
Magnetic resonance imaging  
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 Borgwardt et al (2006) used MRI to assess the prevalence of radiological abnormalities 
in individuals with first-episode psychosis and compared this to individuals at high risk of 
schizophrenia. The rate of radiological abnormality in the first-episode psychosis group was 
40%, but only 2 of the 30 individuals with first episode psychosis had clinically relevant 
pathology – a subdural effusion and right temporal hamartoma. The authors did not identify 
whether these individuals had findings on neurological examination.  
 Similarly,  a case-control study of a clinical and community-based sample found 
radiological abnormalities in 15% of the  former and 6% of the community-based sample 
although none of the abnormalities required intervention or were related to psychosis 
(Falkenberg et al., 2017). Despite this finding, the authors concluded by recommending routine 
MRI in the clinical assessment of all patients presenting with first episode psychosis.   
 A further study used a research sample that excluded individuals with a history of head 
injury, seizures, neurological disease and alcohol or substance use disorder (Lubman et al., 
2002). The authors classified abnormalities as requiring no referral, routine referral or urgent 
referral. In re-examining the cases identified in their sample, two of 152 cases (1.3%) may have 
potentially been casually related to psychosis.  
 Finally, retrospective reviews of the medical records of 349 (Sommer et al., 2013) and 
121 (Pientka et al., 2017) patients with first-episode psychosis found no abnormalities related 
to psychosis.  
Both imaging modalities (CT and MRI)  
 Khandanpour et al (2013) retrospectively reviewed 112 consecutive MRI scans and 204 
consecutive CT scans for individuals with first-episode psychosis but no neurological signs. 
Three of 112 (2.7%) individuals who had MRI and three of 204 (1.5%) individuals who had 
CT had incidental brain lesions potentially accountable for psychosis. This study included older 
patients who were more likely to have an organic cause for psychosis. A second retrospective 
review of 32 consecutive admissions who received a CT, MRI or both, found none had 
incidental brain abnormalities potentially accountable for psychosis (Coentre et al., 2016). Two 
further retrospective reviews of 46 (44 CT and 2 MRI) (Goulet et al., 2009)  and 115 individuals 
(Robert Williams et al., 2014) with first-episode psychosis reported similar negative findings. 
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Discussion 
Clinicians order brain imaging to exclude neurological abnormalities in individuals 
with first-episode psychosis. However, the available data suggest a disappointing yield from 
routine neuroimaging in individuals at low risk of a specific brain abnormality.  
This systematic review includes 2312 individual patients who were scanned with CT 
or MRI. While structural abnormalities were a relatively common finding, these rarely required 
clinical intervention (range across studies: 0-60.7%; median: 3.5%) and were very rarely the 
cause of the psychotic symptoms (range: 0-3.3%; median: 0%). Across all studies, only 10 of 
the 2312 individual subjects had abnormalities that may have been causally related to psychosis 
(0.4%).  It is apparent that incidental radiological abnormalities are more common in older 
individuals, as has been identified in a large meta-analysis of 20,000 individuals (Morris et al., 
2009). This review therefore supports the conclusion by Hollister and Boutros (1991) that older 
age is most predictive of abnormalities in individuals with first-episode psychosis.  
 The clinical utility of a test is related to its diagnostic utility. The diagnostic utility of a 
screening test, such as brain imaging in first episode psychosis, depends on a number of 
variables including the sensitivity and specificity of the test, the prevalence of the disease being 
tested for and the positive predictive value of the test (Adams et al., 1996). The imaging 
modality used will thus have an impact on the number and type of abnormalities detected. This 
is demonstrated in Khandanpour (2013), where more lesions were detected with MRI versus 
CT and in Falkenberg (2017), where the group scanned with 3-T MRI had more abnormal scans 
than those scanned with 1.5-T MRI scans. Other factors which may explain the wide variation 
of abnormalities reported across studies are the prevalence of the abnormalities being tested 
for and the variation in training, experience and reporting methods of the reporting 
radiologist(s). As outlined, the prevalence of neurological conditions explaining psychosis is 
low, although it increases in older individuals. Given the low positive predictive value in first-
onset psychosis in adolescents, false-positive tests will be more common than true-positive 
tests (Adams et al., 1996). In 1000 healthy volunteers, 82% of MRI scans were completely 
normal. Of the ‘abnormal scans’ only 1.1% required urgent referral, with the remainder 
representing false-positive tests that may have caused worry (Katzman et al., 1999). 
 Clinicians continue to order neuroimaging  because of clinical practice guidelines, the  
desire to establish the ‘functional’ character of the psychosis, and a fear of missing a potentially 
treatable cause of psychosis or serious neurological illness, which may result in medicolegal 
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risk (Freudenreich et al., 2009). This may relate to availability bias in the clinician due to a 
misperception of how common causative ‘organic’ findings are, in part due to case reports that 
resonate with clinicians (Rebecca, 2014, John et al., 2017).  
Given the growing amount of data demonstrating the low clinical yield of neuroimaging 
in first-episode psychosis, the Canadian Psychiatric Association  has recently modified  its 
guidelines  from an earlier recommendation that brain imaging be considered as part of a 
routine investigation of all patients with first episode psychosis (Addington et al., 2017). The 
Canadian guidelines now state that ‘imaging is indicated in the presence of signs and symptoms 
suggestive of intracranial pathology including headaches, nausea and vomiting, seizure-like 
activity, and later age at the onset of symptoms’ (Addington et al., 2017). This is reflected in 
the recommendations of Choosing Wisely in both Canada and the United Kingdom that 
clinicians do not routinely order neuroimaging in first-episode psychosis in the absence of signs 
or symptoms suggestive of intracranial pathology (Choosing Wisely Canada, 2017, Choosing 
Wisely UK, 2018). The recommendation of the American Psychiatric Association Practice 
Guidelines for the Psychiatric Evaluation of Adults is that ‘the decision to do laboratory studies 
and other clinical tests, such as imaging studies… should be based on the likelihood that the 
test result will alter diagnostic or treatment-related decision making. The costs of “routine” 
testing, in financial terms and in unneeded evaluations for false positive results, are unlikely to 
offset the benefits of untargeted testing’ (American Psychiatric Association, 2016). Our results 
support this statement with respect to brain imaging in first-episode psychosis. Based on the 
available data, it should not be routinely performed. Prospective studies may provide further 
higher quality data to inform clinical practice (Jonsdottir and Briem, 2016).  
The Royal Australian and New Zealand College of Psychiatrists (RANZCP) guidelines 
highlight the difference in opinion on the need for brain imaging (Galletly et al., 2016). In 
contrast to this uncertainty and the outright opposition to routine scanning in  all cases of first 
episode psychosis in UK and Canadian guidelines, the Australian Orygen guidelines,  updated 
in 2016, continue to recommend neuroimaging in first-episode psychosis (Orygen National 
Centre of Excellence in Youth Mental Health, 2016). This recommendation is not supported 
by the findings of this review.  
While there are research indications for brain imaging in first-episode psychosis, these 
have only identified abnormalities at an aggregated population level rather than in clinical 
settings (Fusar-Poli and Meyer-Lindenberg, 2016, Bartholomeusz et al., 2017). There is no 
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evidence to support the use of voxel-based morphology to diagnose schizophrenia in patients 
with first-episode psychosis (Palaniyappan et al., 2015).  
Even with 6 more studies than earlier reviews, there were only 16 papers, a low number 
considering all MRI studies on FEP. There were limitations in the available studies. Most had 
methodological problems, were of retrospective design and of heterogenous populations. It was 
not clear in several studies whether the same CT or MRI machine was used, what type of 
machine was used or whether scans were reported by the same neuroradiologist. There was a 
risk of selection bias in some studies where patients were included in a non-consecutive 
manner. There was also unclear documentation about whether a neurological examination was 
performed in all studies. No studies provided details of diagnostic measures (sensitivity, 
specificity or area under the curve) or economic analysis. 
Conclusion  
While clinicians must remain cognisant that patients presenting with first-episode 
psychosis have higher rates of underlying neurological abnormalities compared to healthy 
individuals, the available data do not support routine ordering of brain imaging for first-episode 
psychosis in the absence of clinical signs, symptoms or antecedents suggestive of an underlying 
medical or neurological disorder. The appropriate screening procedure for structural brain 
lesions is conventional history-taking, mental status, and neurological examination. If 
intracranial pathology is suspected clinically, an MRI or CT scan should be performed 
depending on the clinical signs, the acuity and the suspected pathology.  
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Figure 1: Search strategy  
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Tables  
Table 1: Guidance about neuroimaging in first-episode psychosis  
Guideline Recommendation 
American Psychiatric Association 
Guidelines for the Treatment of Patients 
with Schizophrenia, Second Edition, 
2010 (American Psychiatric 
Association, 2010) 
A CT or MRI scan may provide helpful 
information, particularly in assessing patients 
with a new onset of psychosis or with an atypical 
clinical presentation. Although imaging studies 
cannot establish a diagnosis of schizophrenia, 
specific findings from a CT or MRI scan (e.g., 
ventricular enlargement, diminished cortical 
volume) may enhance the confidence of the 
diagnosis and provide information that is relevant 
to treatment planning and prognosis. Given the 
subtle nature of the neuropathological findings in 
schizophrenia, MRI is preferred over CT.  
Australian Clinical Guidelines for Early 
Psychosis, 2016 (Orygen National 
Centre of Excellence in Youth Mental 
Health, 2016) 
The following are recommended for all people 
admitted to an early psychosis service (ultra-high 
risk or first-episode psychosis): MRI  
Royal Australian and New Zealand 
College of Psychiatrists clinical 
practice guidelines for the management 
of schizophrenia and related disorders 
(Galletly et al., 2016) 
A comprehensive assessment including physical 
health screening is essential. Expert opinion is 
divided about whether an MRI scan of the brain 
is necessary for all people with first-episode 
psychosis.  
Canadian Guidelines for the Assessment 
and Diagnosis of Patients with 
Schizophrenia Spectrum and Other 
Psychotic Disorders, 2017 (Addington et 
al., 2017) 
Order neuroimaging with computed tomography 
or magnetic resonance imaging based on specific 
aspects of the history, neurological examination, 
or neuropsychological testing results. Consider 
on a case-by-case basis at the time of the first 
episode of psychosis. 
National Institute for Health and Care 
Excellence Guidance for structural 
Structural neuroimaging techniques (either 
magnetic resonance imaging [MRI] or computed 
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neuroimaging in first-episode psychosis, 
2011 (NICE, 2011) 
axial tomography [CT] scanning) are not 
recommended as a routine part of the initial 
investigations for the management of first-
episode psychosis. 
 
 
Table 2:  Quality assessment of methodologic quality   
Study characteristic 1 point 0 points 
Study sample  Clinical sample  Community-based sample 
Details of the study sample  Sufficient details of study 
and/or control populations 
Insufficient details of study 
and/or control populations 
Verification / test 
interpretation 
Independent 
neuroradiologist reviewing 
finding  
Other / not stated  
Patient selection Consecutive Non-consecutive 
Data collection Prospective Non-prospective 
Details of test Sufficient details of 
diagnostic test 
Insufficient details of 
diagnostic test 
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Table 3: Radiological findings  
 
Study Study design N Age 
(mean 
[range or 
SD]) 
Sex 
(M:F) 
Field 
Strength 
(MRI) 
Normal (n/N, 
%) 
Abnormal, benign and/or 
nonspecific (n/N, %) 
Abnormal, may modify 
management and 
treatment, but unlikely 
causal link to psychosis 
(n/N, %) 
Abnormal, may 
modify management  
treatment, possible 
causal link to 
psychosis (n/N, %) 
Limitations / 
Comments 
Adams 
1996 
(Canada)  
Retrospective 
review of 
medical 
records of 
patients with 
CT scans; no 
control group 
98 13-19 Not 
present 
N/A    0/98, 0% Limited data available on 
individual patient scans  
Bain 1998 
(USA) 
 
Retrospective 
review of 
medical 
records of 
patients with 
CT scans; no 
control group 
127 
 
98 aged 
17-30; 
23 aged 
31-40; 
6 aged 
41+ 
102:25 
 
N/A 123/127, 
96.9% 
3/127, 2.4% 
 1 punctate calcification in 
right frontal deep white 
matter 
 1 arachnoid cyst 
 1 left posterior fossa 
arachnoid cyst 
1/127, 0.8% 
 1 suspected pineal 
gland tumour, 
subsequent MRI normal 
0/127, 0% Retrospective design 
Single location 
Battaglia 
1988 
(USA) 
 
Prospective 
diagnostic 
case series 
with CT; no 
control group 
 
45 
 
26 
[17-54] 
30:15 N/A 42/45, 93.3% 1/45, 2.2% 
 1 mild cortical atrophy 
2/45, 4.4% 
 1 possible right frontal 
white matter infarct 
 1 possible left caudate 
infarct 
0/45, 0% 
 
Small sample 
Single location 
Borgwardt
2006 
(Switzerla
nd) 
 
Prospective 
diagnostic 
case series 
with MRI; 
control group 
 
30 30.3 [6.9] 22:8 1.5T MRI  18/30, 60% 12/30, 40% 
 3 generalised atrophy 
 3 neuroepithelial cyst 
 2 frontal atrophy 
 2 single hyperintense 
lesions 
 1 arachnoid cyst 
 1 cavum septi pellucidi 
1/30, 3.3% 
 1 subdural effusion 
1/30, 3.3% 
 1 right temporal 
hamartoma 
Small sample 
Coentre 
2016 
(Portugal) 
Retrospective 
review of 
medical 
records of 
patients with 
CT or MRI 
scan; no 
control group 
32 
(29 
CT, 
1 
MRI, 
2 
both
) 
29.6 [18-
48, 8.7] 
19:13 1.5T MRI  20/32, 62.5% 12/32, 37.5% 
 4 cerebral atrophy 
 3 arachnoid cyst 
 2 asymmetrical lateral 
ventricles 
 1 dilated ventricles 
 1 plagiocephaly 
 1 falx cerebri calcification 
0/32, 0% 0/32, 0% Retrospective design 
Small sample 
Compton 
2009 
(USA)  
Retrospective 
review of 
medical 
records of 
75 22.7 [18-
40, 4.2] 
54:21 N/A 19/75, 25.3% 56/75, 74.7% 
 39 pineal or epithalamus 
calcification 
0/75, 0% 0/75, 0% Retrospective design 
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patients with 
CT; no control 
group 
 9 habenula region 
calcification 
 6 brain volume loss  
 2 cavum septi pellucidum 
/ cavum vergae  
Falkenber
g 2017 
(UK) 
 
Case-control 
(community 
sample) 
MRI scan 
108 Median 
26 [17-
54] 
71:37 1.5T MRI 102/108, 
94.4% 
2/108, 1.9% 
 2 mild asymmetry of 
ventricles, lobes or brain 
 
4/108, 3.7% 
 2 small benign cyst 
 1 white matter 
abnormality 
 1 sella (partially) empty 
0/108, 0%  
Case-control 
(clinical 
sample) 
MRI scan  
241 Median 
24 [14-
56] 
162:79 3.0T MRI  204/241, 
84.6% 
14/241, 5.8% 
 12 cavum septum 
pellucidum 
 2 mild asymmetry of 
ventricles, lobes or brain 
 
23/241, 9.5% 
 14 white matter 
abnormality 
 6 small benign cyst 
 2 sella (partially) empty 
 1 post-ischaemic lesion 
0/241, 0%   
Gewirtz 
1994 
(USA) 
 
Retrospective 
review of 
medical 
records of 
patients with 
CT scan; no 
control group 
 
168 35 [18-
66, 12] 
79:89 
 
N/A 91/168, 54.2% 71/168, 41.1% 
 67 diffuse cortical atrophy 
 2 arachnoid cysts 
 1 cavum septi pellucidum 
and cavum vergae 
 1 venous angiona 
 
3/168, 3.0%  
 1 old right subcortical 
parieto-temporal infarct 
 1 diffuse white matter 
ischaemic change 
 1 moderate-to-large 
temporal arachnoid cyst 
in right temporal area 
 1 old bilateral parietal 
infarction and possible 
subinsular infarct 
 1 bilateral parietal 
ischaemic changes 
1/168, 0.6%  
 1 third ventricle 
colloidal cyst with 
obstruction of 
foramen of Monro 
Retrospective design 
Goulet  
2009 
(Canada) 
Retrospective 
review of 
medical 
records of 
patients with 
CT or MRI 
scan; no 
control group 
46 
(44 
CT, 
2 
MRI) 
29.3 34:12 Not 
provided 
45/46, 97.8% 1/46, 2.2% 
 1 small lipoma just 
above pineal gland 
0/46, 0% 0/46, 0% Retrospective design 
Small sample 
 
Khandanp
our 2012 
(UK) 
Retrospective 
review of 
medical 
records of 
patients with 
CT or MRI 
scan; no 
control group 
316 
(204 
CT, 
112 
MRI) 
CT 
66.8 [19-
95] 
MRI 
59.3 [16-
92] 
CT 
84:120 
MRI 
70:42 
Various 
MRI 
scanners 
used (1.5 – 
3T) 
CT 
68/204, 33.3% 
MRI 
53/112, 47.3% 
CT 
41/204, 20.1% 
 40 cerebral atrophy 
 1 cavernoma 
 
MRI 
47/112, 42.0% 
 37 cerebral atrophy 
 2 cavernoma 
 2 cerebral aneurysm 
CT 
95/204, 46.6% 
 29 old infarct 
 66 small vessel 
ischaemic change 
 
MRI 
68/112, 60.7% 
 17 old infarct 
CT 
3/204, 1.5% 
 1 metastasis 
(primary 
bronchogenic 
carcinoma) 
 1 meningioma 
 1 subependymoma 
 
MRI 
Multiple findings 
documented for each 
patient.  
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 1 absence of septum 
pellucidum 
 1 basal ganglia 
calcification 
 1 calvarial thickening 
 1 arachnoid cyst 
 1 amyloid angiopathy 
 1 mega cisterna magna 
 2 old cerebral 
haemorrhage 
 49 small vessel 
ischaemic change 
 
3/112, 2.7% 
 1 HIV 
encephalopathy 
 1 Primary brain 
tumour 
 1 Paramedian 
meningioma 
Lubman 
2002 
(Australia) 
 
Retrospective 
diagnostic 
case series 
with MRI; 
control group 
152 21.6 [3.5] 104:48 1.5T MRI 118/152, 
77.6% 
21/152, 13.8% 
 7 Prominent sulci / 
ventricles 
 5 white matter 
hyperintensity 
 4 hippocampal asymmetry 
 1 cerebellar ectopia 
 1 craniosynostosis 
 1 chiari 1 malformation 
 1 cavum stepi pellucidum 
 1 cavum of velum 
interpositum 
11/152 7.2% 
 3 pineal cyst 
 1 possible cortical 
dysplasia 
 1 vascular infarction 
 1 minimal 
communicating 
hydrocephalus 
 1 periventricular 
leukomalacia 
 1 pituitary enlargement 
 1 possible Huntington’s 
disease 
 1 vascular lesion (sulcal 
artiovenous 
malformation) 
 1 arachnoid cyst 
2/152, 1.3% 
 2 possible 
demyelinating 
disease 
 
 
McKay 
2006 
(Australia) 
 
Retrospective 
review of 
medical 
records of 
patients with 
CT; no control 
group 
 
52 15-26  N/A 47/52, 90.4% 3/52, 5.8% 2/52, 3.8% 0/52, 0% Retrospective design  
Author contacted and 
provided clarification 
Pientka 
2017 
(USA) 
Retrospective 
review of 
medical 
records of 
patients with 
MRI; no 
control group 
 
121 12-70 82:39 Not 
provided 
104/121, 
86.0% 
13/121, 10.7% 
 9 Non-specific T2 
hyperintense signal  
 2 arachnoid cyst  
 1 venous anomaly  
 1 cavum septa pellucidum 
/ cavum vergae  
4/121, 3.31% 
 1 periventricular 
leukomalacia 
 1 sella (partially) empty 
 1 encephalomalacia  
 1 white matter vessel 
disease 
0/121, 0%  
 
Retrospective design  
Williams 
2014 
(USA) 
Retrospective 
review of 
medical 
records of 
patients with 
115 
(93 
CT, 
14 
MRI, 
8 
12-30  Not 
provided  
109/115, 
94.0% 
5/115, 4.3% 
 1 arachnoid cyst 
 2 mild cerebral atrophy 
 1 white matter 
hyperintensity 
1/115, 0.9% 
 1 berry aneurysm right 
internal carotid 
0/115, 0% Retrospective design 
Single location 
15 
 
CT or MRI; no 
control group 
both
) 
 1 right temporal lobe 
venous angioma 
Strahl 
2010 
(Australia) 
Retrospective 
review of 
medical 
records of 
patients with 
CT; no control 
group 
237 28.3 [16-
72] 
170:67 N/A 192/237, 
81.0% 
42/237, 17.7% 
Including (but not an 
exhaustive list)  
 4 arachnoid cysts 
 4 cerebral atrophy 
 4 mild ventricular 
asymmetry 
12/237, 5.1% 
 12 old infarcts or small 
vessel ischaemic 
change 
0/237, 0% Retrospective design 
Single location 
Sommer 
2013 
(Netherlan
ds)  
Retrospective 
review of 
medical 
records of 
patients with 
MRI; control 
group 
349   1.5T MRI    0/349, 0% No specific data 
provided for the first 
episode psychosis group  
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Table 4: Quality assessment of included studies  
Study Population Details of 
Population  
Verification Patient 
selection 
Data 
collection 
Details of test  Total Score 
Adams (Adams 
et al., 1996) 
1 0 0 1 0 0 2 
Bain (Bain, 
1998) 
1 1 0 0 0 0 2 
Battaglia 
(Battaglia and 
Spector, 1988) 
1 1 0 1 1 0 4 
Borgwardt 
(Borgwardt et 
al., 2006) 
1 1 1 0 1 1 5 
Coentre 
(Coentre et al., 
2016) 
1 1 1 1 0 1 5 
Compton 
(Compton et 
al., 2009) 
1 1 1 1 0 1 5 
Falkenberg 
(clinical) 
(Falkenberg et 
al., 2017) 
1 1 1 0 0 1 4 
Falkenberg 
(community-
based) 
(Falkenberg et 
al., 2017) 
0 1 1 1 0 1 4 
Gewirtz 
(Gewirtz et al., 
1994) 
1 0 1 1 0 0 3 
17 
 
Goulet (Goulet 
et al., 2009) 
1 1 0 0 0 0 2 
Khandanpour 
(Khandanpour 
et al., 2013) 
1 0 0 1 0 1 3 
Lubman 
(Lubman et al., 
2002) 
1 1 1 0 0 1 4 
McKay 
(McKay et al., 
2006) 
1 0 0 0 0 0 1 
Pientka 
(Pientka et al., 
2017) 
1 0 0 0 0 0 1 
Williams (7)  1 0 0 0 0 0 1 
Strahl (Strahl 
et al., 2010) 
1 0 1 1 0 0 3 
Sommer 
(Sommer et al., 
2013) 
1 0 0 1 0 1 3 
  
18 
 
References  
ADAMS, M., KUTCHER, S., ANTONIW, E. & BIRD, D. 1996. Diagnostic utility of endocrine and 
neuroimaging screening tests in first-onset adolescent psychosis. J Am Acad Child Adolesc 
Psychiatry, 35, 67-73; discussion 73. 
ADDINGTON, D., ABIDI, S., GARCIA-ORTEGA, I., HONER, W. G. & ISMAIL, Z. 2017. Canadian Guidelines 
for the Assessment and Diagnosis of Patients with Schizophrenia Spectrum and Other 
Psychotic Disorders. Can J Psychiatry, 62, 594-603. 
ALBON, E., TSOURAPAS, A., FREW, E., DAVENPORT, C., OYEBODE, F., BAYLISS, S., ARVANITIS, T. & 
MEADS, C. 2008. Structural neuroimaging in psychosis: a systematic review and economic 
evaluation. Health Technol Assess, 12, iii-iv, ix-163. 
AMERICAN PSYCHIATRIC ASSOCIATION. 2010. Practice Guideline for the Treatment of Patients with 
Schizophrenia, Second Edition [Online]. American Psychiatric Association. Available: 
https://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/schizop
hrenia.pdf [Accessed]. 
AMERICAN PSYCHIATRIC ASSOCIATION. 2016. The American Psychiatric Association Practice 
Guidelines for the Psychiatric Evaluation of Adults, Third Edition [Online]. Arlington, VA: 
American Psychiatric Association. Available: 
https://psychiatryonline.org/doi/pdf/10.1176/appi.books.9780890426760 [Accessed]. 
BAIN, B. K. 1998. CT scans of first-break psychotic patients in good general health. Psychiatr Serv, 49, 
234-5. 
BARTHOLOMEUSZ, C. F., CROPLEY, V. L., WANNAN, C., DI BIASE, M., MCGORRY, P. D. & PANTELIS, C. 
2017. Structural neuroimaging across early-stage psychosis: Aberrations in neurobiological 
trajectories and implications for the staging model. Aust N Z J Psychiatry, 51, 455-476. 
BATTAGLIA, J. & SPECTOR, I. C. 1988. Utility of the CAT scan in a first psychotic episode. Gen Hosp 
Psychiatry, 10, 398-401. 
BORGWARDT, S. J., RADUE, E. W., GOTZ, K., ASTON, J., DREWE, M., GSCHWANDTNER, U., HALLER, S., 
PFLUGER, M., STIEGLITZ, R. D., MCGUIRE, P. K. & RIECHER-ROSSLER, A. 2006. Radiological 
findings in individuals at high risk of psychosis. J Neurol Neurosurg Psychiatry, 77, 229-33. 
CHOOSING WISELY CANADA. 2017. Psychiatry: thirteen things physicians and patients should question 
[Online]. Available: https://choosingwiselycanada.org/psychiatry/ [Accessed]. 
CHOOSING WISELY UK. 2018. Royal College of Psychiatrists recommendations [Online]. Choosing 
Wisely UK. Available: http://www.choosingwisely.co.uk/i-am-a-
clinician/recommendations/#1476656061018-6802da48-d01a [Accessed]. 
COENTRE, R., SILVA-DOS-SANTOS, A. & TALINA, M. C. 2016. Retrospective study on structural 
neuroimaging in first-episode psychosis. PeerJ, 2016. 
COMPTON, M. T., GOULDING, S. M., WHICKER, N. E., MULLINS, M., NATHAN, S. & RESSLER, K. 2009. 
An exploratory study of the potential prognostic usefulness of the routinely conducted 
computed tomography scan in patients hospitalized for a first episode of psychosis. Clinical 
Schizophrenia and Related Psychoses, 3, 23-30. 
FALKENBERG, I., BENETTI, S., RAFFIN, M., WUYTS, P., PETTERSSON-YEO, W., DAZZAN, P., MORGAN, K. 
D., MURRAY, R. M., MARQUES, T. R., DAVID, A. S., JAROSZ, J., SIMMONS, A., WILLIAMS, S. & 
MCGUIRE, P. 2017. Clinical utility of magnetic resonance imaging in first-episode psychosis. Br 
J Psychiatry, 211, 231-237. 
FREUDENREICH, O., SCHULZ, S. C. & GOFF, D. C. 2009. Initial medical work-up of first-episode 
psychosis: a conceptual review. Early Interv Psychiatry, 3, 10-8. 
FUSAR-POLI, P. & MEYER-LINDENBERG, A. 2016. Forty years of structural imaging in psychosis: 
promises and truth. Acta Psychiatr Scand, 134, 207-24. 
GALLETLY, C., CASTLE, D., DARK, F., HUMBERSTONE, V., JABLENSKY, A., KILLACKEY, E., KULKARNI, J., 
MCGORRY, P., NIELSSEN, O. & TRAN, N. 2016. Royal Australian and New Zealand College of 
19 
 
Psychiatrists clinical practice guidelines for the management of schizophrenia and related 
disorders. Aust N Z J Psychiatry, 50, 410-72. 
GEWIRTZ, G., SQUIRES-WHEELER, E., SHARIF, Z. & HONER, W. G. 1994. Results of computerised 
tomography during first admission for psychosis. Br J Psychiatry, 164, 789-95. 
GOULET, K., DESCHAMPS, B., EVOY, F. & TRUDEL, J. F. 2009. Use of brain imaging (computed 
tomography and magnetic resonance imaging) in first-episode psychosis: review and 
retrospective study. Can J Psychiatry, 54, 493-501. 
HOLLISTER, L. E. & BOUTROS, N. 1991. Clinical use of CT and MR scans in psychiatric patients. J 
Psychiatry Neurosci, 16, 194-8. 
JOHN, K., RICHARD, J. B. & IAIN, E. P. 2017. A case for imaging in high-risk psychosis: insular pathology 
in first episode psychosis. Australian & New Zealand Journal of Psychiatry, 51, 1057-1058. 
JONSDOTTIR, H. & BRIEM, N. 2016. First episode psychosis - The icelandic study. Early Intervention in 
Psychiatry, 10, 141. 
KATZMAN, G. L., DAGHER, A. P. & PATRONAS, N. J. 1999. Incidental findings on brain magnetic 
resonance imaging from 1000 asymptomatic volunteers. Jama, 282, 36-9. 
KHANDANPOUR, N., HOGGARD, N. & CONNOLLY, D. J. 2013. The role of MRI and CT of the brain in first 
episodes of psychosis. Clin Radiol, 68, 245-50. 
LUBMAN, D. I., VELAKOULIS, D., MCGORRY, P. D., SMITH, D. J., BREWER, W., STUART, G., DESMOND, 
P., TRESS, B. & PANTELIS, C. 2002. Incidental radiological findings on brain magnetic resonance 
imaging in first-episode psychosis and chronic schizophrenia. Acta Psychiatr Scand, 106, 331-
6. 
MCKAY, D., GORRELL, J., CORNISH, A., TENNANT, C., ROSEN, A., MOSS, B. & NASH, L. 2006. Let's get 
physical: an audit of medical practice in first episode psychosis. Australas Psychiatry, 14, 146-
9. 
MOHER, D., LIBERATI, A., TETZLAFF, J. & ALTMAN, D. G. 2009. Preferred reporting items for systematic 
reviews and meta-analyses: the PRISMA statement. PLoS Med, 6, e1000097. 
MORRIS, Z., WHITELEY, W. N., LONGSTRETH, W. T., WEBER, F., LEE, Y.-C., TSUSHIMA, Y., ALPHS, H., 
LADD, S. C., WARLOW, C., WARDLAW, J. M. & AL-SHAHI SALMAN, R. 2009. Incidental findings 
on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ, 339. 
NICE. 2011. Structural neuroimaging in first-episode psychosis [Online]. NICE. Available: 
https://www.nice.org.uk/guidance/ta136/documents/review-decision-june-2011 [Accessed]. 
ORYGEN NATIONAL CENTRE OF EXCELLENCE IN YOUTH MENTAL HEALTH. 2016. Australian Clinical 
Guidelines for Early Psychosis, Second Edition [Online]. Orygen. Available: 
https://www.orygen.org.au/Campus/Expert-Network/Resources/Free/Clinical-
Practice/Australian-Clinical-Guidelines-for-Early-Psychosis/Australian-Clinical-Guidelines-for-
Early-Psychosis.aspx?ext [Accessed]. 
PALANIYAPPAN, L., MAAYAN, N., BERGMAN, H., DAVENPORT, C., ADAMS, C. E. & SOARES-WEISER, K. 
2015. Voxel-based morphometry for separation of schizophrenia from other types of 
psychosis in first episode psychosis. Cochrane Database Syst Rev, Cd011021. 
PIENTKA, L. J., SCHULZ, S. C., LIM, K. O. & JASBERG, S. G. 2017. The Clinical Impact of Neuroimaging in 
First-Episode Psychosis. Clin Schizophr Relat Psychoses. 
RAO, S. S., OZTURK, R. & LAINE, L. 2005. Clinical utility of diagnostic tests for constipation in adults: a 
systematic review. Am J Gastroenterol, 100, 1605-15. 
REBECCA, K. 2014. Late onset acute psychosis secondary to primary brain tumour: An initial 
misdiagnosis. Australian & New Zealand Journal of Psychiatry, 48, 1173-1174. 
ROBERT WILLIAMS, S., YUKIO KOYANAGI, C. & SHIGEMI HISHINUMA, E. 2014. On the usefulness of 
structural brain imaging for young first episode inpatients with psychosis. Psychiatry Research 
- Neuroimaging, 224, 104-106. 
SOMMER, I. E., DE KORT, G. A., MEIJERING, A. L., DAZZAN, P., HULSHOFF POL, H. E., KAHN, R. S. & VAN 
HAREN, N. E. 2013. How frequent are radiological abnormalities in patients with psychosis? A 
review of 1379 MRI scans. Schizophr Bull, 39, 815-9. 
20 
 
STRAHL, B., CHEUNG, Y. K. & STUCKEY, S. L. 2010. Diagnostic yield of computed tomography of the 
brain in first episode psychosis. J Med Imaging Radiat Oncol, 54, 431-4. 
WEINBERGER, D. R. 1984. Brain disease and psychiatric illness: when should a psychiatrist order a CAT 
scan? Am J Psychiatry, 141, 1521-7. 
 
